Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 1997

View Archived Issues

Lexicon Genetics granted NIH grant for DNA repair research

ImClone Systems earns manufacturing milestone from Merck KGaA

Iloprost reverses 5-FU-induced delayed wound healing in rats

Ergoset improves metabolism in healthy obese women

Grepafloxacin receives first approval in Germany

Rhone-Poulenc Rorer: Q2 1997 highlights

Nutraceutix in-licenses breast cancer preventive agent

Stanford scientists report breakthrough in polyketide research

New oxazolidinones from P&U

Merck & Co. discloses new substance P antagonists

Janssen reports farnesyl protein transferase inhibitors

Zeneca's Seroquel deemed approvable by FDA

Crinone approved in U.S. for additional indication

Access and The Dow Chemical Company enter into collaboration

Apoptosis Technology and BioChem Pharma to collaborate on anticancer agents

Alteon's pimagedine progresses to phase III

HCV virus isolated and cloned for the first time

Generic warfarin shipments begin

CE certification attained for Carrington Patch; European launch in sight

Seven more marketing approvals announced for Campto

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...